Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and ...

The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...